October 12, 2018
CTI Medical Director Dr. Robert Gaston was the keynote speaker October 10-11 at a workshop entitled “Transplant Success Redefined” in Dallas, Texas.
Organized by The Split Rock Group, a newly-formed, privately-funded “think-tank” devoted to addressing pressing issues in transplantation based in New Haven, CT, the workshop sought to bring fresh perspectives to the ongoing discussion regarding the appropriateness of current performance metrics and clinical endpoints in the field. Chaired by Split Rock founder Dr. Richard Formica of Yale University, the workshop brought together leaders in clinical transplantation, patients, and representatives from CMS, UNOS/OPTN, SRTR, industry, and the FDA. The output from the effort will address a recent call in the Federal Register from CMS for proposals to reduce the regulatory burden on agencies and transplant centers, promoting growth in the field while still ensuring optimal outcomes and safety for patients.
In his address, Dr. Gaston noted the remarkable advances in the field since its clinical origins a century ago, the almost 750,000 solid organ transplants performed in the US since UNOS was created in the mid-1980’s, and the challenges that still confront the field. His themes of developing metrics that facilitate addressing the dual challenges of an inadequate supply of transplantable organs and long-term graft outcomes that continue to fall short of goals for patients and professionals alike were expanded upon by subsequent speakers and vibrant discussion among attendees.
Prior to joining CTI in 2017, Dr. Gaston was Director of the Comprehensive Transplant Institute and holder of the Robert G. Luke Endowed Chair in Transplant Nephrology at UAB. He is also a past president of the American Society of Transplantation (AST) and a recipient of the presitigious AST Lifetime Achievement Award.